dc.contributor.advisor | Conradi, Lena-Christin Dr. | |
dc.contributor.author | Storch, Marcus | |
dc.date.accessioned | 2016-08-22T06:17:27Z | |
dc.date.available | 2016-10-05T22:50:06Z | |
dc.date.issued | 2016-08-22 | |
dc.identifier.uri | http://hdl.handle.net/11858/00-1735-0000-0028-8808-B | |
dc.identifier.uri | http://dx.doi.org/10.53846/goediss-5814 | |
dc.language.iso | deu | de |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject.ddc | 610 | de |
dc.title | Expression des epidermalen Wachstumsfaktorrezeptors Her2/neu in Rektumkarzinomen des lokal fortgeschrittenen Stadiums UICC II / III - Validierung an Patienten der Phase-III-Studien der German Rectal Cancer Study Group | de |
dc.type | doctoralThesis | de |
dc.title.translated | Expression of the epidermal growth-factor-receptor Her2/neu in advanced local rectal cancer UICC II / III - validation on patients of the phase-III-studies of the german rectal cancer study group | de |
dc.contributor.referee | Liersch, Torsten Prof. Dr. | |
dc.date.examination | 2016-09-28 | |
dc.description.abstracteng | Validation of the frequency of the expression of her2/neu in rectal cancer. Her2/neu is an epidermal growth factor receptor known from breast or oesophagus cancer and thought to be a possible therapy target in rectal cancer. | de |
dc.contributor.coReferee | Burfeind, Peter Prof. Dr. | |
dc.subject.ger | CAO/ARO/AIO-04 | de |
dc.subject.ger | Rektumkarzinom | de |
dc.subject.ger | her2/neu | de |
dc.subject.ger | CAO/ARO/AIO-94 | de |
dc.subject.eng | rectal cancer | de |
dc.subject.eng | her2/neu | de |
dc.subject.eng | epidermal growth factor receptor | de |
dc.subject.eng | CAO/ARO/AIO-04 | de |
dc.subject.eng | CAO/ARO/AIO-94 | de |
dc.identifier.urn | urn:nbn:de:gbv:7-11858/00-1735-0000-0028-8808-B-1 | |
dc.affiliation.institute | Medizinische Fakultät | de |
dc.subject.gokfull | GOK-MEDIZIN | de |
dc.description.embargoed | 2016-10-05 | |
dc.identifier.ppn | 869469142 | |